查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434677

动物胜肽市场：依胜胜肽类型、产品来源分类 - 全球预测 2024-2030

Animal Antibacterial Peptide Market by Peptide Type (Anionic Peptides, Cationic Peptides, Linear Cationic Alpha-Helical Peptides), Product Origin (Cattle, Goat, Horse) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年动物胜肽市场规模为34.8亿美元，预计2024年将达40.6亿美元，2030年将达到104亿美元，复合年增长率为16.92%。

全球兽用胜肽市场

主要市场统计
基准年[2023] 34.8亿美元
预测年份 [2024] 40.6亿美元
预测年份 [2030] 104亿美元
复合年增长率（%） 16.92%
动物用抗菌胜肽市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估兽用胜肽市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对兽用胜肽市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-兽用胜肽市场规模及预测为何？

2-在兽用胜肽市场预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-兽用胜肽市场的技术趋势和法律规范是什么？

4-兽用胜肽市场主要供应商的市场占有率是多少？

5-进入兽用胜肽市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 在动物饲料中增加使用低浓度抗生素作为生长促进剂
      • 大量使用抗生素来治疗人类和动物的感染疾病
      • 感染疾病发生率不断增加，对有效和安全药物的需求不断增加
    • 抑制因素
      • 临床应用中的担忧，例如毒性和免疫抗原性
    • 机会
      • 动物保健和新产品开发支出飙升
      • 提高对药物疗法和胜肽治疗方法的认识
    • 任务
      • 抗生素抗药性发生率增加
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 以胜胜肽类型分類的动物用胜肽市场

  • 阴离子胜肽
  • 阳离子胜胜肽
  • 锁状阳离子 A-螺旋胜肽

第七章兽用胜肽市场产品依产地划分

  • 牛
  • 山羊
  • 马
  • 猪
  • 家禽
  • 羊

第8章：美洲动物胜肽市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太兽用胜肽市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲兽用胜肽市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • Amicoat
    • Bayer AG
    • Boehringer Ingelheim GmbH
    • CPC Scientific Inc.
    • Dechra Pharmaceuticals PLC
    • Eli Lilly and Company
    • Endovac Animal Health LLC
    • Fort Dodge Animal Health
    • JPT Peptide Technologies
    • Merck & Co. Inc.
    • Mileutis LTD
    • Sanofi-Aventis Groupe SA
    • Vetoquinol SA
    • Virbac SA
    • Zoetis Inc.
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-4369010662D5

[195 Pages Report] The Animal Antibacterial Peptide Market size was estimated at USD 3.48 billion in 2023 and expected to reach USD 4.06 billion in 2024, at a CAGR 16.92% to reach USD 10.40 billion by 2030.

Global Animal Antibacterial Peptide Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.48 billion
Estimated Year [2024] USD 4.06 billion
Forecast Year [2030] USD 10.40 billion
CAGR (%) 16.92%
Animal Antibacterial Peptide Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Animal Antibacterial Peptide Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Antibacterial Peptide Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Animal Antibacterial Peptide Market, highlighting leading vendors and their innovative profiles. These include Amicoat, Bayer AG, Boehringer Ingelheim GmbH, CPC Scientific Inc., Dechra Pharmaceuticals PLC, Eli Lilly and Company, Endovac Animal Health LLC, Fort Dodge Animal Health, JPT Peptide Technologies, Merck & Co. Inc., Mileutis LTD, Sanofi-Aventis Groupe S.A., Vetoquinol SA, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Antibacterial Peptide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Peptide Type
    • Anionic Peptides
    • Cationic Peptides
    • Linear Cationic A-Helical Peptides
  • Product Origin
    • Cattle
    • Goat
    • Horse
    • Pig
    • Poultry
    • Sheep
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Animal Antibacterial Peptide Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Antibacterial Peptide Market?

3. What are the technology trends and regulatory frameworks in the Animal Antibacterial Peptide Market?

4. What is the market share of the leading vendors in the Animal Antibacterial Peptide Market?

5. Which modes and strategic moves are suitable for entering the Animal Antibacterial Peptide Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Animal Antibacterial Peptide Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of low levels of antibiotics as growth promoters in animal feeds
      • 5.1.1.2. Extensive use of antibiotics to treat human or animal infections
      • 5.1.1.3. Rising frequency of infectious diseases and the rising demand for effective and safe medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns in clinical applications such as the toxicity, and immunogenicity
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid rise in expenditure on animal healthcare and new product development efforts
      • 5.1.3.2. Growing awareness to medications and therapies incorporating antimicrobial peptides
    • 5.1.4. Challenges
      • 5.1.4.1. Proliferating incidences of antibiotic resistance
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Animal Antibacterial Peptide Market, by Peptide Type

  • 6.1. Introduction
  • 6.2. Anionic Peptides
  • 6.3. Cationic Peptides
  • 6.4. Linear Cationic A-Helical Peptides

7. Animal Antibacterial Peptide Market, by Product Origin

  • 7.1. Introduction
  • 7.2. Cattle
  • 7.3. Goat
  • 7.4. Horse
  • 7.5. Pig
  • 7.6. Poultry
  • 7.7. Sheep

8. Americas Animal Antibacterial Peptide Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Animal Antibacterial Peptide Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Animal Antibacterial Peptide Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Amicoat
    • 12.1.2. Bayer AG
    • 12.1.3. Boehringer Ingelheim GmbH
    • 12.1.4. CPC Scientific Inc.
    • 12.1.5. Dechra Pharmaceuticals PLC
    • 12.1.6. Eli Lilly and Company
    • 12.1.7. Endovac Animal Health LLC
    • 12.1.8. Fort Dodge Animal Health
    • 12.1.9. JPT Peptide Technologies
    • 12.1.10. Merck & Co. Inc.
    • 12.1.11. Mileutis LTD
    • 12.1.12. Sanofi-Aventis Groupe S.A.
    • 12.1.13. Vetoquinol SA
    • 12.1.14. Virbac S.A.
    • 12.1.15. Zoetis Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANIMAL ANTIBACTERIAL PEPTIDE MARKET DYNAMICS
  • FIGURE 7. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2023 VS 2030 (%)
  • FIGURE 10. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ANIONIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CATIONIC PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LINEAR CATIONIC A-HELICAL PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 10. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY HORSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PEPTIDE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 102. ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 103. ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. ANIMAL ANTIBACTERIAL PEPTIDE MARKET LICENSE & PRICING